USA flag logo/image

An Official Website of the United States Government

THE LONG TERM OBJECTIVE OF THIS LINE OF INVESTIGATION IS TO DEVELOP A NEW CLASS…

Award Information

Agency:
Department of Defense 		Branch:
Navy 		Award ID:
1994 		Program Year/Program:
1985 / SBIR
Agency Tracking Number:
1994 		Solicitation Year:
N/A 		Solicitation Topic Code:
N/A 		Solicitation Number:
N/A
Small Business Information
Matrix Technologies Inc
2025 Nasa Road 1 Seabrook, TX 77586
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1985
Title: THE LONG TERM OBJECTIVE OF THIS LINE OF INVESTIGATION IS TO DEVELOP A NEW CLASS OF ANTIVIRALS WHICH ARE EFFECTIVE AGAINST A WIDE VARIETY OF INFECTIONS, ARE SAFE FOR HUMAN USE, ECONOMICAL TO PRODUCE AND ENHANCE RESISTANCE TO OR RECOVERY FROM VIRAL
Agency / Branch: DOD / NAVY
Contract: N/A
Award Amount: $49,700.00
 

Abstract:

THE LONG TERM OBJECTIVE OF THIS LINE OF INVESTIGATION IS TO DEVELOP A NEW CLASS OF ANTIVIRALS WHICH ARE EFFECTIVE AGAINST A WIDE VARIETY OF INFECTIONS, ARE SAFE FOR HUMAN USE, ECONOMICAL TO PRODUCE AND ENHANCE RESISTANCE TO OR RECOVERY FROM VIRAL INFECTIOUS AGENTS. THE AGENTS MAY HAVE APPLICATION IN CONJUNCTION WITH KNOWN IMMUNOPOTENTIATORS RECENT EXPERIMENTAL DATA INDICATE THAT A VARIETY OF COMMON ORGANIC AND INORGANIC COMPOUNDS POSSESS DECIDED ANTIVIRAL PROPERTIES AND CONSTITUTE A POTENTIALLY IMPORTANT CLASS OF ANTIVIRAL AGENTS. THE DATA INDICATE THAT THESE AGENTS ARE EFFECTIVE BOTH IN VITRO AND IN VIVO. DURING PHASE I, MATRIX WILL CONDUCT TISSUE CULTURE AND PRELIMINARY INTACT ANIMAL STUDIES OF THE PROPHYLACTIC AND THERAPEUTIC EFFICACY OF FOUR OF THE MOST PROMISING COMPOUNDS AGAINST RESPIRATORY, INFLUENZA AND ENCEPHALITIS VIRUSES.

Principal Investigator:

Dr michael c trachtenberg
7133332982

Business Contact:

Small Business Information at Submission:

Matrix Technologies Inc
2025 Nasa Road 1 Seabrook, TX 77586

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No